Forekom på forskellige tidspunkter op til flere måneder efter afslutningen af behandlingen med MabThera 5 Fortrinsvis set hos patienter med tidligere hjertesygdom og/ eller kardiotoksisk kemoterapi.
Occurred at various times up to several months after completion of MabThera therapy 5 observed mainly in patients with prior cardiac condition and/ or cardiotoxic chemotherapy and were mostly associated with infusion-related reactions 6 includes fatal cases